2nd Annual Pharma Packaging, Labelling, Serialization, Track & Trace 2019

08:30 – Coffee and registration – An opportunity to meet and to network with your conference colleagues.

09:30 - Chairperson opening remarks

MARKET OVERVIEW & ANALYSIS

09:40 – Anti-Counterfeiting legislation and the mandate - In Indian Context

GOURI SHANKAR, Assistant drugs controller (I) (Legal Cell), CDSCO-HQ

10:20 – Regulatory requirement for serialisation and its significance

OMPRAKASH S. SADHWANI, Former Joint Commissioner and controlling Authority, Food and Drug Administration (Maharashtra state)

10:50 – Morning Coffee / Tea & Discussion

CHALLENGES & OPPORTUNITIES

11:10 – DISCUSSION WITH EXPERTS: Efforts to secure your products from illegal counterfeiting and catching the counterfeiters

•   Current scenario of anti-counterfeiting in India for the pharmaceuticals products
•   Challenges to stay ahead with counterfeiters becoming smarter and more sophisticated than ever before.
•   Anti-counterfeiting legislation and the mandate; how will your company incorporate these changes into your anti-counterfeiting strategy?
•   Absolute techniques to secure packaging and to avoid counterfeiting
•   Effective anti-counterfeit strategy to avoid brand loyalty compromised and to ensure patient safety
•   Ensuring pharmaceutical companies are working subsequently to protect their services and reputations by educating their clients on counterfeit products and acquiring a holistic view of all online channels where their brand is being infringed

Moderator
S.R.SALUNKHE, Former Assistant commissioner, FDA Maharashtra

Panellists
UDAYKUMAR RAKIBE, Founder, PharmaMantra
SANJAY DAVE, CCO, Anfarnd Consultancy Services
SUNIL ACHARYA, Packaging Development, S.C.P.L
BIMAL MEHTA, CEO, Vakils Premedia

11:50 – DISCUSSION WITH EXPERTS: Importance of implementing serialization and track & trace to your pharmaceuticals production

•   Major benefit of adopting to a new specialized software’s which manages high level of serialization complexity
•   Using of microscopic serialization codes to track pharmaceutical products
•   How different is the traceability regulatory concepts based on serialization of medicines which impacts the stakeholders across the supply chain?
•   What are the traceability challenges still to be overcome in the next 3 to 5 years?
•   Why do we need a harmonized global strategy in terms of controls in the supply chain in order to protect efficiently patients from counterfeits?
•   Global regulatory end-to-end tracking process and its critical functionality

Moderator
FAHEEM AGBOATWALA, Director, Hi-Tech Printing Services

Panellists
GOURI SHANKAR, Assistant drugs controller (I) (Legal Cell), CDSCO-HQ
RITESH GOHEL, Senior Manager, Global Serialisation and Track & Trace, Sun Pharma
JAGDISH VYAS, Manager, Abbott
VIRENDRA SINGH, Senior Manager, Reliance Life Sciences
SANTOSH THAKUR, Head Of Procurement, Koye Pharma

12:30 - Networking luncheon

Afternoon Chair Person

VISHWAS SOVANI, Founder Director, Pharmawisdom

13:40 – Pharma Packaging: sustainability a global challenge

•   Global impact
•   Environment damage
•   Global Bans
•   How to be sustainable

AMIT KALE, Associate Vice President - Packaging and Automation, Reliance

14:10 – Connecting Commodity with Community through Packaging & Labelling

•   What Commodity-Community connectivity actually means?
•   Why is it important to establish this connectivity?
•   How is it established through Packaging & Labelling?
•   How can this be enhanced and strengthened?
•   What are the challenges and resolutions?

PRABIR DAS, Head - Packaging Tech Services, OSD, Mylan Laboratories

14:40 – DISCUSSION WITH EXPERTS: Designing your packaging and labelling which is more secure and attractive to your clients and the consumers

•   Considering patient adherence and patient persistence as part of the packaging and labeling
•   Encouraging innovative packaging designs to assure your products stand out against those of the competition
•   Perfecting your packaging to assure your products integrity is guaranteed both while in storage and in transit
•   Gaining enterprise labelling to uphold compliance, protect brand and perfecting supply chain performance
•   Looking at the packaging design that encourage patient adherence to prescribed medicine regime
•   Best practice guide to gain advantage on your product labelling
•   Considerations to improve the efficiency of product logistics through labelling optimisation
•   Learning about industry best activity solutions to better your labelling analyse activity and distinguishing potential errors

Moderator
VISHWAS SOVANI, Founder Director, Pharmawisdom

Panellists
AMIT KALE, Associate Vice President - Packaging and Automation, Reliance
PRABIR DAS, Head - Packaging Tech Services, OSD, Mylan Laboratories
RAJSHRI CHETAN PARDESHI, Manager - Packaging Development & Labelling, Glenmark Pharmaceuticals
DARSHAN VARTAK, Head Packaging Technical, Anchor by Panasonic
SUKHDEV SINGH SAINI, Packaging Lead, Colgate Palmolive

15:20 – Afternoon Tea / Coffee

REGULATORY

15:40 – Current Status of Counterfeit Medicines in our Society

SACHEEN GANDHI, Co Founder Health & Environment Research (FHER) 100 Most Impactful Healthcare Leader (Global Listing ) by World Health Congress

16:00 - DISCUSSION WITH EXPERTS: Understanding the global regulatory developments and updates

•   Recent evolving regulatory frameworks in India – Compared with RoW
•   How regulation seeks to respond the legal framework and most efficient strategies to combat counterfeiting
•   Establishing a secure market for consumers to ensure the protection of legitimate trade
•   Establishing measures that promote strong IP rights enforcement in coordination with rights holders and trading partners
•   How government seeks to regulate IoT and emergent technology to address the counterfeiting challenge
•   A holistic strategy that includes collaboration with law enforcement authorities, regulatory officials, supply chain partners, and packaging technology specialists
•   What governments expect from brand holders and pharmaceutical stakeholders?
•   Regulatory requirements – What is the greater emphasis on supplying the global market

Moderator
KINJAL PARIKH, Research Associate, FTF Pharma

Panellists
VIKAS BIYANI, Asst.Commissioner (Drugs), FDA Maharashtra
PRIYA CHATTERJEE, Director - Regulatory Affairs, Merck India
NARESH TONDARE, Senior Director - National Regulatory Affairs, Biocon
VISHAL MHATRE, Associate Vice President - Regulatory Affairs, Tata Consultancy Services
RAJESH PEDNEKAR, Head - Supply Chain Operations and Strategy, Healthcare SF

16:40 - Chairperson’s closing remarks and end of conference

VISHWAS SOVANI, Founder Director, Pharmawisdom